Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire
Open Access
- 1 January 2013
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 131 (3) , 166-172
Abstract
CONTEXT AND OBJECTIVE Patients with beta-thalassemia major (β-TM) experience physical, psychological and social problems that lead to decreased quality of life (QoL). The aim here was to measure health-related QoL and its determinants among patients with β-TM, using the Short Form-36 (SF-36) questionnaire. DESIGN AND SETTING Cross-sectional study at the Hematology Research Center of Shiraz University of Medical Sciences, in southern Iran. METHODS One hundred and one patients with β-TM were randomly selected. After the participants' demographics and disease characteristics had been recorded, they were asked to fill out the SF-36 questionnaire. The correlations of clinical and demographic factors with the QoL score were evaluated. RESULTS There were 44 men and 57 women of mean age 19.52 ± 4.3 years (range 12-38). On two scales, pain (P = 0.041) and emotional role (P = 0.009), the women showed significantly lower scores than the men. Lower income, poor compliance with iron-chelating therapy and presence of comorbidities were significantly correlated with lower SF-36 scores. These factors were also found to be determinants of worse SF-36 scores in multivariate analysis. CONCLUSIONS We showed that the presence of disease complications, poor compliance with iron-chelating therapy and poor economic status were predictors of worse QoL among patients with β-TM. Prevention and proper management of disease-related complications, increased knowledge among patients regarding the importance of managing comorbidities and greater compliance with iron-chelating therapy, along with psychosocial and financial support, could help these patients to cope better with this chronic disease state.Keywords
This publication has 30 references indexed in Scilit:
- The Experiences of Adolescents With Thalassemia in West Bengal, IndiaQualitative Health Research, 2007
- Health related quality of life in Malaysian children with thalassaemiaHealth and Quality of Life Outcomes, 2006
- Quality of Life in Patients with Thalassemia Intermedia Compared to Thalassemia MajorAnnals of the New York Academy of Sciences, 2005
- The Thalassemias: The Role of Molecular Genetics in an Evolving Global Health Problem**Previously presented at the annual meeting of The American Society of Human Genetics, in Los Angeles, on November 7, 2003.The American Journal of Human Genetics, 2004
- Quality-of-life evaluation using Short Form 36: Comparison in hemodialysis and peritoneal dialysis patientsAmerican Journal of Kidney Diseases, 2000
- Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) ProjectJournal of Clinical Epidemiology, 1998
- Global Epidemiology of Hemoglobin DisordersAnnals of the New York Academy of Sciences, 1998
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992